Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to test the efficacy of 2 tablets (twice daily) of
ABT-712, compared to placebo, administered over a 4-week period in participants with moderate
to severe mechanical chronic low back pain (CLBP).